No Data
No Data
No Data
No Data
No Data
As More Rare Disease Therapies Launch, Their Prices Are Rising
Seeking AlphaApr 16 12:22 ET
Form 144 | Amicus Therapeutics(FOLD.US) Director Proposes to Sell 311.67K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Amicus Therapeutics(FOLD.US)$ Director JOHN F CROWLEY intends to sell 29,183 shares of its common stock on Apr 15, with a total market value of approximately $311.67K.
moomoo NewsApr 15 16:31 ET
Amicus Therapeutics(FOLD.US) Officer Sells US$87,495.75 in Common Stock
$Amicus Therapeutics(FOLD.US)$ Officer Campbell Bradley L sold 7,500 shares of Common Stock on Apr 1, 2024 at an average price of $11.6661 for a total value of $87,495.75.Source: Announcement What is
moomoo NewsApr 3 18:57 ET
Form 144 | Amicus Therapeutics(FOLD.US) Director Proposes to Sell 343.75K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Amicus Therapeutics(FOLD.US)$ Director JOHN F CROWLEY intends to sell 29,181 shares of its common stock on Apr 1, with a total market value of approximately $343.75K.
moomoo NewsApr 1 16:29 ET
Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
Simply Wall StApr 1 07:39 ET
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Yahoo FinanceMar 29 11:30 ET
No Data
No Data